Table 2.
Urine cultures in each group of patients
| Urine culture | THA Group A (with urinary treatment) | THA Group B (without treatment) | HA Group A (with urinary treatment) | HA Group B (without treatment) |
|---|---|---|---|---|
| Positive urine culture (> 100,000 CFUs) in total series | 3/111 (2.7%) | 5/117 (4.3%) | 23/117 (20%) | 15/126 (12%) |
| Positive urine culture (> 100,000 CFUs) in patients with abnormal urinalysis | 3/35 (8.6%) | 5/31 (16%) | 23/60 (38%) | 15/55 (27%) |
| Bacteria identified in positive urine cultures (specific antibiotics administered to patients in Group A) (bacteria sensible [Y] or not sensible [N] to cephazolin used for prophylaxis protocol) | 1 Pseudomonasaeruginosa (fosfo) 1 Escherichia coli (amox-clavul) 1 Klebsiella pneumoniae (cipro) |
3 E coli (1Y, 2N) 1 P aeurginosa (N) 1 Proteus mirabilis (N) |
5 E coli (amox-clav) 4 E coli (fosfo) 2 E coli (cipro) 1 P aeruginosa (cipro) 1 P aeruginosa (levo) 1 P aeruginosa (fosfo) 1 P aeruginosa (cefta+cipro) 1 P mirabilis (amox-clav) 1 P mirabilis (imipenem) 1 Enterococcus faecalis (amox-clav) 1 E faecalis (cipro) 1 Klebsiella oxytoca (amox-clav) 1 K pneumoniae + M. morganii (CMX) 1 Citrobacter freundii (cipro) 1 mixed flora (amox-clav) |
8 E coli (4 Y, 4 N) 2 Paeruginosa (N) 1 Escherichia cloacae (N) 1 E faecalis (N) 1 E coli + P aeruginosa (N) 1 E coli + E faecalis (N) 1 E coli + P mirabilis (N) |
| Repeated urine cultures with gross contamination (exclusion criteria) | 2/111 (1.8%) | 0/117 (0%) | 9/117 (7.7%) | 11/126 (8.7%) |
HA = hemiarthroplasty; CFUs = colony-forming units; Y = yes; N = no; fosfo = fosfomicin; amox-clavul = amoxicillin-clavulanic; cipro = ciprofloxacin; levo = levofloxacin; cefta = ceftazidime; CMX = cotrimoxazole.